The invention relates to indole acetic acid compounds which function as
antagonists of the CRTH2 receptor. The invention also relates to the use
of these compounds to inhibit the binding of prostaglandin D.sub.2 and
its metabolites or certain thromboxane metabolites to the CRTH2 receptor
and to treat disorders responsive to such inhibition.